WO2007012907A2 - Electric therapy machine - Google Patents
Electric therapy machine Download PDFInfo
- Publication number
- WO2007012907A2 WO2007012907A2 PCT/IB2005/000314 IB2005000314W WO2007012907A2 WO 2007012907 A2 WO2007012907 A2 WO 2007012907A2 IB 2005000314 W IB2005000314 W IB 2005000314W WO 2007012907 A2 WO2007012907 A2 WO 2007012907A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- machine
- signals
- supervision
- administered
- subject
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/326—Applying electric currents by contact electrodes alternating or intermittent currents for promoting growth of cells, e.g. bone cells
Definitions
- This invention relates to the application to the human body of electrical stimuli, in order to facilitate remedial or curative effects with respect to damage, illness and disease.
- Such treatment may better consist of such stimuli in the form of simple, variable, or sequentially compounded pulses of signal, of a high voltage amplitude.
- the object of the present invention is to provide a means by which potentially harmful electrical stimuli may be safely administered, without risk of the aforementioned harm being inflicted upon the person being subjected to the said treatment, thus rendering the treatments safe for unsupervised self- administration.
- the required remedial signals, or signal sequences are contained within a 'safety envelope' that comprises a suitable signal content, which is designed to be able to inflict intolerable discomfort on the recipient, whilst still at levels below those which might render any other signal elements of the envelope detrimental.
- this effect is realised by ensuring that the safety element of the signal lies within that signal band, which is known to cause maximum stimulation of the body's sensory nervous system.
- this safety system is achieved by ensuring that with all combinations of the nerve stimulating and remedial signals, the mean power of the potentially damaging signals is always pro-rata less than that of the nerve stimulating signals, ensuring that intolerable discomfort would prevent potentially damaging signal levels being administered.
- the degree of safety that can be realised by the said safety envelope method renders such treatment suitable for unsupervised, self- administration, by a subject, whether medically trained or not.
- such a 'safety envelope' may be produced as a 'leading' voltage pulse of nominally 275 microseconds duration, followed by a 'null' period ostensibly of no signal, some 8 to 64 times the pulse's actual duration.
- a 'leading' voltage pulse of nominally 275 microseconds duration
- a 'null' period ostensibly of no signal, some 8 to 64 times the pulse's actual duration.
- signals as may be required for any particular treatment (which might be harmful at too high a level) may be inserted, such inserted signals having enforced limits (irrespective of the data by which means they are prescribed) such limits rendering them not unacceptably harmful.
- the 'leading' pulse may be varied over a band of circa 150 to 350 microseconds, according to the required effects.
- remedial signals as may be inserted into the 'envelope' described by the said lead pulse plus the null period, may be of a complex nature in as much as any number of pulses, with any number of intervening nulls, of a positive or negative or bi-polar nature, of any duration capable of being resolved by the circuitry (circa 1 microsecond minimum) may be prescribed, but only up to the resolved 'safe' total power.
- the above described envelopes may be repeated, with changes to the signal content being effected between envelopes, or between 'blocks' of envelopes, and/or between 'sequences' of such blocks, and/or between 'sessions' of such sequences.
- all such changes to the signals as mentioned above may be prescribed, either by the microprocessor program, or by the program data stored in the EEPROM, or both, and effected by means of commonly understood programming procedures.
- This example describes a machine as a specific embodiment of the invention as may be employed for all types of the pulsed electrical therapy.
- Figure 1 shows the electrical circuit of the machine that is capable of being programmed, and so fixed, so as to produce and supply the remedial and safety signals, only in the required safe ratios.
- Figure 1 One or more pairs of electrodes, suitable for application to the requisite parts of the body, are led by conductive, insulated wires from the 'OUTPUT' such that electrical current may be caused to pass between them, through the subject's body tissue.
- the wires are fed from the secondary (high voltage) winding of an electrical transformer 'FTR', via a voltage level-controlling device 'VRl', and a resistive current limiting device 'Rl', such that the subject is able to raise the output signal voltage only to a level, that does not inflict undue discomfort.
- the primary winding of the transformer is supplied with pulses of current by the switching device 'FET'.
- the switching device 'FET' is fed via the switching transistor 'TRl', with signals generated by a fixed program microprocessor, 'up', the controlling program of which is designed such that irrespective of any manual adjustments that may be made to the unit, or any controlling data that may be introduced to influence the program, the level or degree of discomfort inducing signal will always be safely higher than that of any other possibly detrimental signal.
- This embodiment also provides, but not essentially, a means of introducing new or altered treatment program instruction data, via a PC interface, as shown in Figure 1 as 'IN CLK, IN DAT, OUT CLK, OUT DAT'.
- This program data is stored in the re-programmable memory device 'EEPROM'.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cell Biology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Electrotherapy Devices (AREA)
Abstract
An electrical machine capable of generating complex and compounded electrical signals, which may be applied to the human body for the purpose of effecting therapeutic, remedial and/or curative results, but which is rendered incapable of administering such signals at levels which might cause damage or other harm, by essentially containing a proportion of signals which, at high levels, will inflict unendurable discomfort. Such inclusions being unavoidably present at relative levels safely above those which might present the risk of unacceptable consequences.
Description
ELECTRIC THERAPYMACHINE
Field of the Invention
This invention relates to the application to the human body of electrical stimuli, in order to facilitate remedial or curative effects with respect to damage, illness and disease.
Background of the Invention
It is known that certain types of electrical stimuli, when passed through human tissue, can effect restorative or curative activity, with respect to damage, illness and disease.
It is also known that such treatment may better consist of such stimuli in the form of simple, variable, or sequentially compounded pulses of signal, of a high voltage amplitude.
It is also known that certain types of such stimuli can effect considerable damage or harm to human tissue, if not advisedly administered.
It is also known that certain types of suitably remedial electrical signals, may inflict such damage or harm, without exciting awareness in the subject to whom they are applied, requiring such treatment to be administered only by suitably trained persons.
It is also known that a particular signal construct, consisting of repeated high voltage pulses centred around 250 milliseconds duration, each followed by a sustained period of no voltage, has profound effects upon the body's nervous system, such as may inflict extreme discomfort, whilst nevertheless resulting in no significant damage.
It is also known that these nerve stimulating types of signal, and much shorter duration types of pulses, which may be remedial, but not essentially nerve stimulating, may both reasonably be produced by means of a circuit comprising a low voltage microprocessor signal generator, a current switching amplifier and a low to high voltage transformer.
The Invention
The object of the present invention is to provide a means by which potentially harmful electrical stimuli may be safely administered, without risk of the aforementioned harm being inflicted upon the person being subjected to the said treatment, thus rendering the treatments safe for unsupervised self- administration.
According to the invention, the required remedial signals, or signal sequences, are contained within a 'safety envelope' that comprises a suitable signal content, which is designed to be able to inflict intolerable discomfort on the recipient, whilst still at levels below those which might render any other signal elements of the envelope detrimental.
According to the invention, this effect is realised by ensuring that the safety element of the signal lies within that signal band, which is known to cause maximum stimulation of the body's sensory nervous system.
According to the invention, this safety system is achieved by ensuring that with all combinations of the nerve stimulating and remedial signals, the mean power of the potentially damaging signals is always pro-rata less than that of the nerve stimulating signals, ensuring that intolerable discomfort would prevent potentially damaging signal levels being administered.
According to the invention, the degree of safety that can be realised by the said safety envelope method, renders such treatment suitable for unsupervised, self- administration, by a subject, whether medically trained or not.
According to the invention, such a 'safety envelope' may be produced as a 'leading' voltage pulse of nominally 275 microseconds duration, followed by a 'null' period ostensibly of no signal, some 8 to 64 times the pulse's actual duration. Into this null period such signals as may be required for any particular treatment (which might be harmful at too high a level) may be inserted, such inserted signals having enforced limits (irrespective of the data by which means they are prescribed) such limits rendering them not unacceptably harmful.
According to the invention, the 'leading' pulse may be varied over a band of circa 150 to 350 microseconds, according to the required effects.
According to the invention, such remedial signals as may be inserted into the 'envelope' described by the said lead pulse plus the null period, may be of a complex nature in as much as any number of pulses, with any number of intervening nulls, of a positive or negative or bi-polar nature, of any duration capable of being resolved by the circuitry (circa 1 microsecond minimum) may be prescribed, but only up to the resolved 'safe' total power.
According to the invention, the above described envelopes may be repeated, with changes to the signal content being effected between envelopes, or between 'blocks' of envelopes, and/or between 'sequences' of such blocks, and/or between 'sessions' of such sequences.
According to the invention, all such changes to the signals as mentioned above, may be prescribed, either by the microprocessor program, or by the program data stored in the EEPROM, or both, and effected by means of commonly understood programming procedures.
Embodiment of the Invention
This example describes a machine as a specific embodiment of the invention as may be employed for all types of the pulsed electrical therapy.
Figure 1 shows the electrical circuit of the machine that is capable of being programmed, and so fixed, so as to produce and supply the remedial and safety signals, only in the required safe ratios.
Referring to the drawing, Figure 1: One or more pairs of electrodes, suitable for application to the requisite parts of the body, are led by conductive, insulated wires from the 'OUTPUT' such that electrical current may be caused to pass between them, through the subject's body tissue.
The wires are fed from the secondary (high voltage) winding of an electrical transformer 'FTR', via a voltage level-controlling device 'VRl', and a resistive current limiting device 'Rl', such that the subject is able to raise the output signal voltage only to a level, that does not inflict undue discomfort.
The primary winding of the transformer is supplied with pulses of current by the switching device 'FET'.
The switching device 'FET' is fed via the switching transistor 'TRl', with signals generated by a fixed program microprocessor, 'up', the controlling program of which is designed such that irrespective of any manual adjustments that may be made to the unit, or any controlling data that may be introduced to influence the program, the level or degree of discomfort inducing signal will always be safely higher than that of any other possibly detrimental signal.
This embodiment also provides, but not essentially, a means of introducing new or altered treatment program instruction data, via a PC interface, as shown in Figure 1 as 'IN CLK, IN DAT, OUT CLK, OUT DAT'. This program data is stored in the re-programmable memory device 'EEPROM'.
Other circuit aspects of Figure 1 provide conventional facilities, which are not essential to the invention.
Claims
1. A machine capable of supplying high voltage electrical, therapeutic signals, but incapable of administering seriously damaging levels of such, for any period of time that might result in actual damage.
2. A machine as claimed in Claim 1, wherein any required mix of otherwise dangerous therapeutic signals can be programmed into the device with complete safety.
3. A single machine as claimed in Claim 1 or Claim 2, that is able to be programmed with a range of differing signals such that a substantial range of differing damage, illness or disease may be safely treated.
4. A machine as claimed in Claim 1 or Claim 2, whereby already widely known, but potentially hazardous treatments, only currently available under trained supervision, may be safely self-administered by a subject without the need for such supervision.
5. A machine as claimed in Claim 1 or Claim 2, whereby newly discovered, but potentially hazardous treatments, may be safely self-administered by a subject without the need of supervision.
6. A machine as claimed in Claim 1, or Claim 2, whereby theoretically probable, but potentially hazardous treatments, may be safely self- administered by a subject without a need of supervision.
7. A machine as claimed in Claim 1 or Claim 2, that is capable of disabling mitotic body cells, such that unwanted growth is prevented or reversed.
8. A machine as claimed in Claim 1 or Claim 2, that is capable of disabling malignant (cancer) cells, and so effect the mortality of such.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IB2005/000314 WO2007012907A2 (en) | 2005-02-08 | 2005-02-08 | Electric therapy machine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IB2005/000314 WO2007012907A2 (en) | 2005-02-08 | 2005-02-08 | Electric therapy machine |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007012907A2 true WO2007012907A2 (en) | 2007-02-01 |
WO2007012907A3 WO2007012907A3 (en) | 2009-01-15 |
Family
ID=37683705
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2005/000314 WO2007012907A2 (en) | 2005-02-08 | 2005-02-08 | Electric therapy machine |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2007012907A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3085414A1 (en) * | 2015-04-22 | 2016-10-26 | BIOTRONIK SE & Co. KG | Device and method for selective nerve stimulation |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4784737A (en) * | 1986-04-18 | 1988-11-15 | The United States Department Of Energy | Electromicroinjection of particles into living cells |
US6233482B1 (en) * | 1997-08-01 | 2001-05-15 | Genetronics, Inc. | Method of electroporation mediated delivery of drugs and genes |
US6366808B1 (en) * | 2000-03-13 | 2002-04-02 | Edward A. Schroeppel | Implantable device and method for the electrical treatment of cancer |
US6418341B1 (en) * | 1993-04-01 | 2002-07-09 | Genetronics, Inc. | Needle electrode assembly for electroporation mediated delivery of genes and drugs |
US20020099323A1 (en) * | 1998-07-13 | 2002-07-25 | Nagendu B. Dev | Skin and muscle-targeted gene therapy by pulsed electrical field |
-
2005
- 2005-02-08 WO PCT/IB2005/000314 patent/WO2007012907A2/en not_active Application Discontinuation
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4784737A (en) * | 1986-04-18 | 1988-11-15 | The United States Department Of Energy | Electromicroinjection of particles into living cells |
US6418341B1 (en) * | 1993-04-01 | 2002-07-09 | Genetronics, Inc. | Needle electrode assembly for electroporation mediated delivery of genes and drugs |
US6233482B1 (en) * | 1997-08-01 | 2001-05-15 | Genetronics, Inc. | Method of electroporation mediated delivery of drugs and genes |
US20020099323A1 (en) * | 1998-07-13 | 2002-07-25 | Nagendu B. Dev | Skin and muscle-targeted gene therapy by pulsed electrical field |
US6366808B1 (en) * | 2000-03-13 | 2002-04-02 | Edward A. Schroeppel | Implantable device and method for the electrical treatment of cancer |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3085414A1 (en) * | 2015-04-22 | 2016-10-26 | BIOTRONIK SE & Co. KG | Device and method for selective nerve stimulation |
US9895542B2 (en) | 2015-04-22 | 2018-02-20 | Biotronik Se & Co. Kg | Device and method for selective nerve stimulation |
Also Published As
Publication number | Publication date |
---|---|
WO2007012907A3 (en) | 2009-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10569089B1 (en) | Spinal cord modulation for inhibiting pain via short pulse width waveforms, and associated systems and methods | |
AU2014340652B2 (en) | Implantable head mounted neurostimulation system for head pain | |
US5974342A (en) | Electrical stimulation therapy method and apparatus | |
US8812115B2 (en) | System and method for reducing excitability of dorsal root fiber by introducing stochastic background noise | |
US10086201B2 (en) | Electronic stimulation device, method of treatment and electronic stimulation system | |
US4431002A (en) | Modulated deep afferent stimulator | |
JP2016523173A (en) | Paddle leads and lead arrangements for dorsal angle stimulation and methods and systems using the leads | |
US20060142822A1 (en) | Externally activated neuro-implant which directly transmits therapeutic signals | |
WO1997036645A2 (en) | Electrotherapy device | |
Toda et al. | Local electrical stimulation: effective needling points for suppressing jaw opening reflex in rat | |
US20240033530A1 (en) | Neurostimulators and stimulation systems | |
US6735476B2 (en) | Electrical stimulation device and methods of treatment of various body conditions | |
JP2005537069A (en) | Integrated deep percutaneous / surface electrical stimulation | |
AU2003263037A2 (en) | Combined percutaneous/surface electrical stimulation | |
US10183165B2 (en) | Method of reducing renal hypertension and computer-readable medium | |
WO2007012907A2 (en) | Electric therapy machine | |
US20040088021A1 (en) | System and method for treatment of sexual dysfunction | |
EP2837405B1 (en) | Applicator head for treatment of pain by transcutaneous electrical nerve stimulation | |
US9119963B1 (en) | Electric device for producing successive positive and negative electric charges | |
GB2410688A (en) | Electro therapy device for self-administration with output signal safety-envelope | |
US20170361105A1 (en) | Systems and methods of combined tonic dbs and random dbs | |
US10632310B2 (en) | Electronic stimulation device, method of treatment and electronic stimulation system | |
US20200009375A1 (en) | Device, system and method for killing viruses in blood through electrode wires | |
CN110870946A (en) | Device for stimulating the reins and/or the medullary veins and/or the retroflexion in the brain | |
Wong | Use of electrostimulation of acupuncture points in general dental practice. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase in: |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 05702456 Country of ref document: EP Kind code of ref document: A2 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 5702456 Country of ref document: EP |